{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:58:44Z","timestamp":1794362324379,"version":"4.9.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.npep.2022.102285","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T22:27:01Z","timestamp":1662157621000},"page":"102285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models"],"prefix":"10.1016","volume":"96","author":[{"given":"Masoume","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Tebianian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Tofigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh Sadat","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Alireza","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asal","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayla","family":"Munawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koorosh","family":"Shahpasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2022.102285_bb0005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuron.2011.07.027","article-title":"Single units in the medial prefrontal cortex with anxiety-related firing patterns are preferentially influenced by ventral hippocampal activity","volume":"71","author":"Adhikari","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2022.102285_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02005-x","article-title":"Cellular infiltration in traumatic brain injury","volume":"17","author":"Alam","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.npep.2022.102285_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01068-4","article-title":"Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae","volume":"8","author":"Albayram","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2022.102285_bb0020","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2017.5218","article-title":"The biological basis of chronic traumatic encephalopathy following blast injury: a literature review","volume":"34","author":"Aldag","year":"2017","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.npep.2022.102285_bb0025","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/jcm10071446","article-title":"ANCA-associated Vasculitis: An update","volume":"10","author":"Almaani","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.npep.2022.102285_bb0030","doi-asserted-by":"crossref","first-page":"e793","DOI":"10.1212\/WNL.0000000000010040","article-title":"Late contributions of repetitive head impacts and TBI to depression symptoms and cognition","volume":"95","author":"Alosco","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1538\/expanim.60.111","article-title":"Strain and sex differences in anxiety-like and social behaviors in C57BL\/6J and BALB\/cJ mice","volume":"60","author":"An","year":"2011","journal-title":"Exp. Anim."},{"key":"10.1016\/j.npep.2022.102285_bb0040","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamaneurol.2017.2396","article-title":"Research gaps and controversies in chronic traumatic encephalopathy: a review","volume":"74","author":"Asken","year":"2017","journal-title":"JAMA neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mcn.2017.03.003","article-title":"Systemic and network functions of the microtubule-associated protein tau: implications for tau-based therapies","volume":"84","author":"Bakota","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","article-title":"Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans","volume":"75","author":"Barnes","year":"2018","journal-title":"JAMA neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104642","article-title":"Epigenetic mechanisms of neurodegenerative diseases and acute brain injury","volume":"133","author":"Bertogliat","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2022.102285_bb0060","doi-asserted-by":"crossref","first-page":"fcz004","DOI":"10.1093\/braincomms\/fcz004","article-title":"Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury","volume":"1","author":"Bittar","year":"2019","journal-title":"Brain Communications"},{"key":"10.1016\/j.npep.2022.102285_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.expneurol.2010.05.010","article-title":"Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice","volume":"224","author":"Boimel","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cns.13378","article-title":"Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury","volume":"26","author":"Bonsack","year":"2020","journal-title":"CNS neuroscience & therapeutics"},{"key":"10.1016\/j.npep.2022.102285_bb0075","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/13854040500246935","article-title":"Does effort suppress cognition after traumatic brain injury? A re-examination of the evidence for the Word Memory Test","volume":"20","author":"Bowden","year":"2006","journal-title":"The Clinical Neuropsychologist"},{"key":"10.1016\/j.npep.2022.102285_bb0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fnins.2020.00616","article-title":"Recent preclinical insights into the treatment of chronic traumatic encephalopathy","volume":"14","author":"Breen","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02699052.2017.1380228","article-title":"Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice","volume":"32","author":"Broussard","year":"2018","journal-title":"Brain Inj."},{"key":"10.1016\/j.npep.2022.102285_bb0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","article-title":"Astrocyte roles in traumatic brain injury","volume":"275","author":"Burda","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fneur.2019.00198","article-title":"Cognitive impairment following acute mild traumatic brain injury","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818774223","article-title":"The role of prefrontal\u2013subcortical circuitry in negative bias in anxiety: translational, developmental and treatment perspectives","volume":"2","author":"Carlisi","year":"2018","journal-title":"Brain and Neuroscience Advances"},{"key":"10.1016\/j.npep.2022.102285_bb0105","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.3233\/JAD-132477","article-title":"Specific targeting of tau oligomers in htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds","volume":"40","author":"Castillo-Carranza","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.npep.2022.102285_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2016.09.027","article-title":"Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?","volume":"60","author":"Collins-Praino","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.npep.2022.102285_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062402","article-title":"Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity","volume":"8","author":"d\u2019Abramo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2022.102285_bb0120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ymthe.2022.01.009","article-title":"Inhibition of tau seeding by targeting tau nucleation core within neurons with a single domain antibody fragment","volume":"30","author":"Danis","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.npep.2022.102285_bb0125","first-page":"1","article-title":"Long-term effects of mild traumatic brain injuries to oculomotor tracking performances and reaction times to simple environmental stimuli","volume":"8","author":"Danna-Dos-Santos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2022.102285_bb0130","unstructured":"Defense and Veterans Brain Injury Center. Department of Defense 1\u20135 (Washington, DC, 2018)."},{"key":"10.1016\/j.npep.2022.102285_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-00924-7","article-title":"Biological links between traumatic brain injury and Parkinson\u2019s disease","volume":"8","author":"Delic","year":"2020","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.npep.2022.102285_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000369787","article-title":"Interactions between traumatic brain injury and frontotemporal degeneration","volume":"39","author":"Deutsch","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.npep.2022.102285_bb0145","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.npep.2022.102285_bb0150","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1523\/JNEUROSCI.1898-15.2016","article-title":"Interfering with the chronic immune response rescues chronic degeneration after traumatic brain injury","volume":"36","author":"Ert\u00fcrk","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0155","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","article-title":"Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways","volume":"22","author":"Evans","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.npep.2022.102285_bb0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S2215-0366(18)30065-8","article-title":"Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study","volume":"5","author":"Fann","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.npep.2022.102285_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52892-6.00001-5","article-title":"Epidemiology of traumatic brain injury","volume":"127","author":"Faul","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/neu.2015.3958","article-title":"Repetitive mild traumatic brain injury in the developing brain: effects on long-term functional outcome and neuropathology","volume":"33","author":"Fidan","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.npep.2022.102285_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrn.2017.39","article-title":"How and why do T cells and their derived cytokines affect the injured and healthy brain?","volume":"18","author":"Filiano","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0180","doi-asserted-by":"crossref","DOI":"10.1080\/14737159.2022.2035723","article-title":"Neuroimaging with PET\/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward","author":"Filippi","year":"2022","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.npep.2022.102285_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuron.2015.05.019","article-title":"Dealing with danger in the CNS: the response of the immune system to injury","volume":"87","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2022.102285_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0340-6","article-title":"Targeting tauopathy with engineered tau-degrading intrabodies","volume":"14","author":"Gallardo","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.npep.2022.102285_bb0195","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005522","article-title":"Mild TBI and risk of Parkinson disease: a chronic effects of neurotrauma consortium study","volume":"90","author":"Gardner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12974-018-1069-9","article-title":"Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in mice","volume":"15","author":"Garg","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.npep.2022.102285_bb0205","first-page":"1","article-title":"Mild traumatic brain injuries and future risk of developing Alzheimer\u2019s disease: systematic review and Meta-analysis","author":"Graham","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.npep.2022.102285_bb0210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2015.04.003","article-title":"Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell\u2013cell communication by chemokines","volume":"36","author":"Gyoneva","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.npep.2022.102285_bb0215","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1523\/JNEUROSCI.2402-19.2020","article-title":"Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits","volume":"40","author":"Henry","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0384-9","article-title":"Immunotherapy to improve cognition and reduce pathological species in an Alzheimer\u2019s disease mouse model","volume":"10","author":"Herline","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.npep.2022.102285_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022297","article-title":"Ten-year trends in traumatic brain injury: a retrospective cohort study of California emergency department and hospital revisits and readmissions","volume":"8","author":"Hsia","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.npep.2022.102285_bb0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","article-title":"Innate immune responses to trauma","volume":"19","author":"Huber-Lang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.npep.2022.102285_bb0235","first-page":"301","article-title":"Chronic traumatic encephalopathy: known causes, unknown effects","volume":"28","author":"Iacono","year":"2017","journal-title":"Physical Medicine and Rehabilitation Clinics"},{"key":"10.1016\/j.npep.2022.102285_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0245","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1089\/neu.2008.0676","article-title":"Closed head injury in a mouse model results in molecular changes indicating inflammatory responses","volume":"26","author":"Israelsson","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.npep.2022.102285_bb0250","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/ijms22020907","article-title":"Repetitive traumatic brain injury causes neuroinflammation before tau pathology in adolescent P301S mice","volume":"22","author":"Izzy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2022.102285_bb0255","series-title":"Traumatic Brain Injury as a Trigger of Neurodegeneration","author":"Johnson","year":"2017"},{"key":"10.1016\/j.npep.2022.102285_bb0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-3-319-57193-5_15","article-title":"Traumatic brain injury as a trigger of neurodegeneration","author":"Johnson","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.npep.2022.102285_bb0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbi.2014.05.020","article-title":"Exploratory associations with tumor necrosis factor-\u03b1, disinhibition and suicidal endorsement after traumatic brain injury","volume":"41","author":"Juengst","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.npep.2022.102285_bb0270","first-page":"1","article-title":"Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs","author":"Kalra","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.npep.2022.102285_bb0275","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bph.13125","article-title":"The contribution of astrocytes and microglia to traumatic brain injury","volume":"173","author":"Karve","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2022.102285_bb0280","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1073858419848293","article-title":"Brain injury\u2013mediated neuroinflammatory response and Alzheimer\u2019s disease","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"key":"10.1016\/j.npep.2022.102285_bb0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/cns.12360","article-title":"Mechanisms and potential therapeutic applications of microglial activation after brain injury","volume":"21","author":"Kim","year":"2015","journal-title":"CNS neuroscience & therapeutics"},{"key":"10.1016\/j.npep.2022.102285_bb0290","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0295","series-title":"Seminars in Neurology","article-title":"Emerging therapies in traumatic brain injury","volume":"83","author":"Kochanek","year":"2015"},{"key":"10.1016\/j.npep.2022.102285_bb0300","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.npep.2022.102285_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau\u2013tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.npep.2022.102285_bb0310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2014.12.021","article-title":"Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome","volume":"45","author":"Kumar","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.npep.2022.102285_bb0315","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2019.07.039","article-title":"A review of the molecular mechanisms of traumatic brain injury","volume":"131","author":"Ladak","year":"2019","journal-title":"World neurosurgery"},{"key":"10.1016\/j.npep.2022.102285_bb0320","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-016-8093-4","article-title":"Traumatic brain injury and age at onset of cognitive impairment in older adults","volume":"263","author":"Li","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0325","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.npep.2022.102285_bb0330","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13854046.2016.1257069","article-title":"Traumatic brain injury history is associated with earlier age of onset of Alzheimer disease","volume":"31","author":"LoBue","year":"2017","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.npep.2022.102285_bb0335","first-page":"97","article-title":"Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities","volume":"11","author":"Lozano","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.npep.2022.102285_bb0340","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.apmr.2014.10.026","article-title":"Randomized controlled trials in adult traumatic brain injury: a review of compliance to CONSORT statement","volume":"96","author":"Lu","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.npep.2022.102285_bb0345","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jamaneurol.2016.2027","article-title":"Potential of the antibody against cis\u2013phosphorylated tau in the early diagnosis, treatment, and prevention of Alzheimer disease and brain injury","volume":"73","author":"Lu","year":"2016","journal-title":"JAMA neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.npep.2022.102285_bb0355","article-title":"Role of tau acetylation in Alzheimer\u2019s disease and chronic traumatic encephalopathy: the way forward for successful treatment","volume":"4","author":"Lucke-Wold","year":"2017","journal-title":"Journal of neurology and neurosurgery"},{"key":"10.1016\/j.npep.2022.102285_bb0360","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23858","article-title":"Clinical correlates in an experimental model of repetitive mild brain injury","volume":"74","author":"Mannix","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.npep.2022.102285_bb0370","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2016.00556","article-title":"Emerging roles for the immune system in traumatic brain injury","volume":"7","author":"McKee","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.npep.2022.102285_bb0375","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12248","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"25","author":"McKee","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.npep.2022.102285_bb0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-444-63954-7.00028-8","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"158","author":"Mckee","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0385","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1227\/NEU.0b013e318265a439","article-title":"Increasing recovery time between injuries improves cognitive outcome after repetitive mild concussive brain injuries in mice","volume":"71","author":"Meehan","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.npep.2022.102285_bb0390","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2017.8334","article-title":"Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football","volume":"318","author":"Mez","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.npep.2022.102285_bb0395","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.3390\/ijms22126418","article-title":"Pathophysiological responses and roles of astrocytes in traumatic brain injury","volume":"22","author":"Michinaga","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2022.102285_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.740939","article-title":"Traumatic brain injury: mechanisms of glial response","volume":"12","author":"Mira","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.npep.2022.102285_bb0405","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/acn3.510","article-title":"Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury","volume":"5","author":"Mouzon","year":"2018","journal-title":"Annals of clinical and translational neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0410","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","article-title":"Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer\u2019s disease","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.npep.2022.102285_bb0415","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-180586","article-title":"Traumatic brain injury and age of onset of dementia with Lewy bodies","volume":"66","author":"Nguyen","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.npep.2022.102285_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002496","article-title":"Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study","volume":"15","author":"Nordstr\u00f6m","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.npep.2022.102285_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0436-1","article-title":"FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease","volume":"10","author":"Novak","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.npep.2022.102285_bb0430","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","article-title":"ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer\u2019s disease","volume":"1","author":"Novak","year":"2021","journal-title":"Nature Aging"},{"key":"10.1016\/j.npep.2022.102285_bb0435","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","article-title":"Tau immunotherapy for Alzheimer\u2019s disease","volume":"21","author":"Pedersen","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.npep.2022.102285_bb0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15585\/mmwr.mm6909a2","article-title":"Deaths from fall-related traumatic brain injury\u2014United States, 2008\u20132017","volume":"69","author":"Peterson","year":"2020","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.npep.2022.102285_bb0445","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0023677216675010","article-title":"Severity assessment and scoring for neurosurgical models in rodents","volume":"50","author":"Pinkernell","year":"2016","journal-title":"Lab. Anim."},{"key":"10.1016\/j.npep.2022.102285_bb0450","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.expneurol.2017.11.003","article-title":"Single severe traumatic brain injury produces progressive pathology with ongoing contralateral white matter damage one year after injury","volume":"300","author":"Pischiutta","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17313-1","article-title":"Prophylactic active tau immunization leads to sustained reduction in both tau and amyloid-\u03b2 pathologies in 3xTg mice","volume":"7","author":"Rajamohamedsait","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2022.102285_bb0460","doi-asserted-by":"crossref","DOI":"10.4045\/tidsskr.17.0763","article-title":"Risk factors for frontotemporal dementia","author":"Rasmussen","year":"2018","journal-title":"Tidsskrift for Den norske legeforening."},{"key":"10.1016\/j.npep.2022.102285_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer\u2019s disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.npep.2022.102285_bb0470","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","article-title":"Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein","volume":"63","author":"Rosenmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0475","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.expneurol.2013.07.006","article-title":"Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation","volume":"248","author":"Rozenstein-Tsalkovich","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1624-z","article-title":"Blast traumatic brain injury and serum inflammatory cytokines: a repeated measures case-control study among US military service members","volume":"17","author":"Rusiecki","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.npep.2022.102285_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125614","article-title":"Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models","volume":"10","author":"Sankaranarayanan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2022.102285_bb0490","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1089\/neu.2010.1318","article-title":"Effects of traumatic brain injury of different severities on emotional, cognitive, and oxidative stress-related parameters in mice","volume":"27","author":"Schwarzbold","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.npep.2022.102285_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.npep.2022.102285_bb0500","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1242\/jcs.147553","article-title":"Cdk5 activity in the brain\u2013multiple paths of regulation","volume":"127","author":"Shah","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.npep.2022.102285_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.825086","article-title":"\u2019Microglia and Neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced Neurodegeneration","volume":"14","author":"Shao","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.npep.2022.102285_bb0510","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000354491","article-title":"Tau immunotherapy and imaging","volume":"13","author":"Sigurdsson","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.npep.2022.102285_bb0515","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.npep.2022.102285_bb0520","series-title":"Share & Trends Analysis Report By Device (Imaging, Monitoring), By Technique (ICP, pBrO2), By End Use, By Region, And Segment Forecasts, 2020\u20132027","author":"Traumatic Brain Injury Assessment & Management Devices Market Size","year":"2022"},{"key":"10.1016\/j.npep.2022.102285_bb0525","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","article-title":"Targeting phospho-Ser422 by active tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach","volume":"9","author":"Troquier","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.npep.2022.102285_bb0530","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jocn.2017.03.035","article-title":"Chronic traumatic encephalopathy: the cellular sequela to repetitive brain injury","volume":"41","author":"Vile","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0535","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/glia.23171","article-title":"Sexual dimorphism in the inflammatory response to traumatic brain injury","volume":"65","author":"Villapol","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.npep.2022.102285_bb0540","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0545","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0550","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2015.05.013","article-title":"Traumatic brain injury causes frontotemporal dementia and TDP-43 proteolysis","volume":"300","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2022.102285_bb0555","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1523\/JNEUROSCI.0291-15.2015","article-title":"Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment","volume":"35","author":"Webster","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2022.102285_bb0560","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1474-4422(17)30279-X","article-title":"The chronic and evolving neurological consequences of traumatic brain injury","volume":"16","author":"Wilson","year":"2017","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.npep.2022.102285_bb0565","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/glia.23523","article-title":"Traumatic brain injury-induced neuronal damage in the somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation","volume":"66","author":"Witcher","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.npep.2022.102285_bb0570","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4103\/1673-5374.255958","article-title":"Acute drivers of neuroinflammation in traumatic brain injury","volume":"14","author":"Wofford","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.npep.2022.102285_bb0575","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fneur.2013.00018","article-title":"The role of markers of inflammation in traumatic brain injury","volume":"4","author":"Woodcock","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.npep.2022.102285_bb0580","first-page":"4503","article-title":"Traumatic brain injury results in cellular, structural and functional changes resembling motor neuron disease","volume":"27","author":"Wright","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.npep.2022.102285_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01161-2","article-title":"Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes","volume":"9","author":"Xu","year":"2021","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.npep.2022.102285_bb0590","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2022.102285_bb0595","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11064-018-02714-z","article-title":"MiR-124 enriched exosomes promoted the M2 polarization of microglia and enhanced hippocampus neurogenesis after traumatic brain injury by inhibiting TLR4 pathway","volume":"44","author":"Yang","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.npep.2022.102285_bb0600","article-title":"Neuroinflammation following traumatic brain injury: take it seriously or not","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417922000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417922000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:38:37Z","timestamp":1758919117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417922000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":120,"alternative-id":["S0143417922000609"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2022.102285","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2022.102285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102285"}}